A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
NCT05279456
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
Advax-CpG55.2 adjuvanted recombinant spike protein
Sponsor
Vaxine Pty Ltd
Collaborators
[object Object]